Plasma matrix metalloproteinase (mmp)-9 levels are reduced following low-calorie cranberry juice supplementation in men

Journal of the American College of Nutrition

Volumn 28, Issue 6, 2009, Pages 694-701

  Ruel, Guillaume ^a   Pomerleau, Sonia ^a   Couture, Patrick ^b   Lemieux, Simone ^a,b   Lamarche, Benoît ^a,b   Couillard, Charles ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cardiovascular disease; Cranberry; Flavonoids; MMP 9

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; BEVERAGE; BLOOD; BLOOD PRESSURE; CALORIC INTAKE; CLINICAL TRIAL; CRANBERRY; DIET SUPPLEMENTATION; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; BEVERAGES; BLOOD PRESSURE; DIETARY SUPPLEMENTS; ENERGY INTAKE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TREATMENT OUTCOME; VACCINIUM MACROCARPON;

EID: 77955891641     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2009.10719803     Document Type: Article

References (50)

1. Cooke JP: The endothelium: a new target for therapy. Vasc Med 5:49-53, 2000.
2. American Heart Association: “Heart Disease and Stroke Statistics-2005 Update.” Dallas: NHA National Center, p 1, 2005.
3. Michiels C: Endothelial cell functions. J Cell Physiol 196:430-443, 2003.
4. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration-the multistep paradigm. Cell 76:301-314, 1994.
5. Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, Papazachou OG, Hatzizacharias AN, Perrea D, Votteas V: Changes in metalloproteinases in healthy normotensive patients with highnormal blood pressure. Eur Cytokine Netw 16:211-214, 2005.
6. Pascarella L, Penn A, Schmid-Schonbein GW: Venous hypertension and the inflammatory cascade: major manifestations and trigger mechanisms. Angiology 56:S3-S10, 2005.
7. Upchurch GR, Ford JW, Weiss SJ, Knipp BS, Peterson DA, Thompson RW, Eagleton MJ, Broady AJ, Proctor MC, Stanley JC: Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro. J Vasc Surg 34:76-82, 2001.
8. Eagleton MJ, Peterson DA, Sullivan VV, Roelofs KJ, Ford JA, Stanley JC, Upchurch GR: Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression. J Surg Res 104:15-21, 2002.
9. Deleve LD, Wang XD, Kanel GC, Ito Y, Bethea NW, McCuskey MK, Tokes ZA, Tsai J, McCuskey RS: Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 38:900-908, 2003.
10. Demacq C, Metzger IF, Gerlach RF, Tanus-Santos JE: Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers. Clin Chim Acta 394:72-76, 2008.
11. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC: Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337:1491-1499, 1997.
12. Bazzano LA, Liu S, Serdula MK: Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr Atheroscl Rep 5:492-499, 2003.
13. Rahman I, Biswas SK, Kirkham PA: Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72:1439-1452, 2006.
14. Matchett MD, MacKinnon SL, Sweeney MI, Gottschall-Pass KT, Hurta RAR: Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells. Biochem Cell Biol 83:637-643, 2005.
15. Dell’Agli M, Canavesi M, Galli G, Bellosta S: Dietary polyphenols and regulation of gelatinase expression and activity. Thromb Haemosta 93:751-760, 2005.
16. Sartor L, Pezzato E, Dell’Aica I, Caniato R, Biggin S, Garbisa S: Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug design. Biochem Pharmacol 64:229-237, 2002.
17. Ende C, Gebhardt R: Inhibition of matrix metalloproteinase-2 and -9 activities by selected flavonoids. Plant Med 70:1006-1008, 2004.
18. Hakkinen SH, Karenlampi SO, Heinonen IM, Mykkanen HM, Torronen AR: Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agri Food Chem 47:2274-2279, 1999.
19. Vvedenskaya IO, Rosen RT, Guido JE, Russell DJ, Mills KA, Vorsa N: Characterization of flavonols in cranberry (Vaccinium macrocarpon) powder. J Agric Food Chem 52:188-195, 2004.
20. Maatta-Riihinen KR, Kahkonen MP, Torronen AR, Heinonen IM: Catechins and procyanidins in berries of Vaccinium species and their antioxidant activity. J Agric Food Chem 53:8485-8491, 2005.
21. Chen H, Zuo YG, Deng YW: Separation and determination of flavonoids and other phenolic compounds in cranberry juice by high-performance liquid chromatography. J Chromatogr A 913: 387-395, 2001.
22. Wang PL, Du CT, Francis FJ: Isolation and characterization of polyphenolic compounds in cranberries. J Food Sci 43:1402-1404, 1978.
23. Wang Y, Catana F, Yang YN, Roderick R, van Breemen RB: An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem 50:431-435, 2002.
24. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C: Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr 96:357-364, 2006.
25. Vanderkooy K, Seidell JC: Techniques for the measurement of visceral fat-a practical guide. Int J Obes 17:187-196, 1993.
26. Moorjani S, Dupont A, Labrie F, Lupien, PJ, Brun D, Gagne C, Giguere M, Belanger A: Increase in plasma high-density- lipoprotein concentration following complete androgen blockage in men with prostatic-carcinoma. Metabolism 36:244-250, 1987.
27. Burstein M, Samaille J: Sur un dosage rapide du cholesterol lie aux alpha-lipoproteines et aux beta-lipoproteines du serum. Clin Chim Acta 5:609-609, 1960.
28. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C: Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr 99:352-359, 2008.
29. Koh KK, Son JW, Ahn JY, Jin DK, Kim HS, Choi YM, Kim DS, Jeong EM, Park GS, Choi IS, Shin EK: Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease. Arterioscler Thromb Vasc Biol 22:E19-E23, 2002.
30. Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ: Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 100:1657-1665, 2006.
31. Tate P, God J, Bibb R, Lu Q, Larcom LL: Inhibition of metallopro- teinase activity by fruit extracts. Cancer Lett 212:153-158, 2004.
32. Bodet C, Chandad F, Grenier D: Inhibition of host extracellular matrix destructive enzyme production and activity by a high- molecular-weight cranberry fraction. J Periodontal Res 42:159-168, 2007.
33. Bodet C, Chandad F, Grenier D: Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res 85:235-239, 2006.
34. Lee B, Moon SK: Resveratrol inhibits TNF-alpha-induced proliferation and matrix metlloproteinase expression in human vascular smooth muscle cells. J Nutr 135:2767-2773, 2005.
35. Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS, Lee YH, Park JW, Kwon TK: Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23:1845-1853, 2004.
36. Matchett MD, MacKinnon SL, Sweeney MI, Gottschall-Pass KT, Hurta RAR: Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events. J Nutr Biochem 17:117-125, 2006.
37. Zheng W, Wang SY: Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonber- ries. J Agric Food Chem 51:502-509, 2003.
38. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PRF, Thompson MM, Thompson M: Increased matrix metallopro- teinase-9 activity in unstable carotid plaques A potential role in acute plaque disruption. Stroke 31:40-47, 2000.
39. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix-degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503, 1994.
40. Gurjar, MV, Sharma RV, Bhalla RC: eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscl Thromb Vasc Biol 19:2871-2877, 1999.
41. Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, Vitek MP, Roberts DD, Wink DA: Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc Natl Acad SciUSA 104:16898-16903, 2007.
42. Knipp BS, Ailawadi G, Ford JW, Peterson DA, Eagleton MJ, Roelofs KJ, Hannawa KK, Deogracias MP, Ji B, Logsdon C, Graziano KD, Simeone DM, Thompson RW, Henke PK, Stanley JC, Upchurch GR: Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear Factor-kappa B and activator protein-1 activity. J Surg Res 116:70-80, 2004.
43. Mariotto S, Menegazzi M, Suzuki H: Biochemical aspects of nitric oxide. Curr Pharm Des 10:1627-1645, 2004.
44. Maher MA, Mataczynski H, Stephaniak HM, Wilson T: Cranberry juice induces nitric oxide dependent vasodilation and transiently reduces blood pressure in conscious and anaesthetized rats. J Med Food 3:141-147, 2000.
45. Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, Barter PJ: Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscl Thromb Vasc Biol 25:2416-2421, 2005.
46. Kurowska EM, Spence JD, Jordan J, Wetmore S, Freeman DJ, Piche LA, Serratore P: HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72:1095-1100, 2000.
47. Freedman JE, Parker C, Li LQ, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD, Folts JD: Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103:2792-2798, 2001.
48. Keevil JG, Osman HE, Reed JD, Folts JD: Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 130:53-56, 2000.
49. O’Byrne DJ, Devaraj S, Grundy SM, Jialal I: Comparison of the antioxidant effects of Concord grape juice flavonoids and alpha- tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr 76:1367-1374, 2002.
50. Ruel G, Pomerleau S, Couture P, Lamarche B, Couillard C: Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism 54:856-861, 2005.